Associations Between Cerebral Small-Vessel Disease and Alzheimer Disease Pathology as Measured by Cerebrospinal Fluid Biomarkers

JAMA Neurology - United States
doi 10.1001/jamaneurol.2014.754
Full Text
Abstract

Available in full text

Categories
Neurology
Date
Authors
Publisher

American Medical Association (AMA)

Related search

Relations Between Personality Changes and Cerebrospinal Fluid Biomarkers of Alzheimer's Disease Pathology

Journal of Psychiatric Research
PsychiatryBiological PsychiatryMental Health
2017English

Cerebrospinal Fluid Neurogranin and YKL-40 as Biomarkers of Alzheimer's Disease

Annals of Clinical and Translational Neurology
NeuroscienceNeurology
2015English

Cerebrospinal Fluid Tau and Phosphotau as Biomarkers in Alzheimer's Disease Diagnosis

Basic and Clinical Neuroscience
Molecular NeuroscienceNeurologyCellular
2019English

Neuroimaging in Cerebral Small Vessel Disease

Journal of Neurology and Neuromedicine
2018English

Neurogranin as a Cerebrospinal Fluid Biomarker for Synaptic Loss in Symptomatic Alzheimer Disease

JAMA Neurology
Neurology
2015English

Predicting Cognitive Decline in Subjects at Risk for Alzheimer Disease by Using Combined Cerebrospinal Fluid, MR Imaging, and PET Biomarkers

Radiology
Nuclear MedicineRadiologyImaging
2013English

The Association Between Frailty and MRI Features of Cerebral Small Vessel Disease

Scientific Reports
Multidisciplinary
2019English

Neuropsychiatric Correlates of Cerebrospinal Fluid Biomarkers in Alzheimer’s Disease

Dementia and Geriatric Cognitive Disorders
PsychiatryGerontologyGeriatricsMental HealthCognitive Neuroscience
2008English

Primary Open Angle Glaucoma Is Associated With MR Biomarkers of Cerebral Small Vessel Disease

Scientific Reports
Multidisciplinary
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy